Article info
PDFEditorial
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
- Professor D L Scott, Academic Department of Rheumatology, King’s College London School of Medicine, Weston Education Centre, King’s College London, 10 Cutcombe Road, London SE5 9RS, UK; david.l.scott{at}kcl.ac.uk
Citation
New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
Publication history
- Accepted March 10, 2009
- First published May 12, 2009.
Online issue publication
March 09, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and European League Against Rheumatism